<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: In this study we sought to evaluate the clinical significance of serum autoantibodies to dementing processes </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We assessed 40 age-matched subjects: 10 patients with probable <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, 10 with possible <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> with cerebrovascular disease, 10 with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, and 10 nondemented control subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Serum from each subject was tested for the presence of antithyroglobulin antibody, thyroid antimicrosomal antibody, gastric anti-parietal cell antibody, anti-smooth muscle antibody, antinuclear antibody, rheumatoid factor, antineuronal antibody, and anticardiolipin antibody </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, we investigated the sera of these patients for the presence of an antivascular antibody directed against the vascular basement membrane <z:chebi fb="0" ids="37396">proteoglycan</z:chebi> antigen and for circulating immune complexes </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Autoantibodies were present in 100% of the patients with possible <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> with cerebrovascular disease, 80% of those with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, 40% of those with probable <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, and 30% of the nondemented control subjects </plain></SENT>
<SENT sid="5" pm="."><plain>The highest number of autoantibodies was observed in patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and possible <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> with cerebrovascular disease </plain></SENT>
<SENT sid="6" pm="."><plain>Antinuclear antibody was present in 60% of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> patients and antineuronal antibody in 50% of these patients </plain></SENT>
<SENT sid="7" pm="."><plain>However, no individual autoantibody could differentiate <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> from cerebrovascular disorders </plain></SENT>
<SENT sid="8" pm="."><plain>Immune complexes were detected in the serum of 20-30% of each patient group </plain></SENT>
<SENT sid="9" pm="."><plain>Neither the patient nor the control sera was found to contain antiendothelial antibody </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Despite the relatively small number of individuals examined in each category, the elevated number of autoantibodies associated with possible <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> with cerebrovascular disease and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> indicates a possible link between the presence of autoantibodies and cerebrovascular disorders in <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>